0000950123-24-008225.txt : 20240813
0000950123-24-008225.hdr.sgml : 20240813
20240813163630
ACCESSION NUMBER: 0000950123-24-008225
CONFORMED SUBMISSION TYPE: 13F-HR
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20240630
FILED AS OF DATE: 20240813
DATE AS OF CHANGE: 20240813
EFFECTIVENESS DATE: 20240813
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: SR ONE CAPITAL MANAGEMENT, LP
CENTRAL INDEX KEY: 0001910264
ORGANIZATION NAME:
IRS NUMBER: 843397640
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 13F-HR
SEC ACT: 1934 Act
SEC FILE NUMBER: 028-21964
FILM NUMBER: 241202289
BUSINESS ADDRESS:
STREET 1: 985 OLD EAGLE SCHOOL ROAD
STREET 2: SUITE 511
CITY: WAYNE
STATE: PA
ZIP: 19087
BUSINESS PHONE: (610) 766-2240
MAIL ADDRESS:
STREET 1: 985 OLD EAGLE SCHOOL ROAD
STREET 2: SUITE 511
CITY: WAYNE
STATE: PA
ZIP: 19087
13F-HR
1
primary_doc.xml
X0202
13F-HR
LIVE
0001910264
XXXXXXXX
06-30-2024
06-30-2024
false
SR One Capital Management, LP
985 Old Eagle School Road
Suite 511
Wayne
PA
19087
13F HOLDINGS REPORT
028-21964
000306361
801-119142
N
Sasha Keough
General Counsel and CCO
(410) 800-7503
/s/ Sasha Keough
Timonium
MD
08-13-2024
0
9
319401842
false
INFORMATION TABLE
2
34916.xml
INFORMATION TABLE FOR FORM 13F
Alumis Inc.
Common Stock
022307102
26066617
1959896
SH
SOLE
1959896
0
0
Arcellx, Inc.
Common Stock
03940C100
129510510
2346630
SH
SOLE
2346630
0
0
ARS Pharmaceuticals, Inc.
Common Stock
82835W108
34149805
4012903
SH
SOLE
4012903
0
0
CRISPR Therapeutics AG
Common Shares
H17182108
56653844
1048951
SH
SOLE
1048951
0
0
Design Therapeutics, Inc.
Common Stock
25056L103
21863695
6526476
SH
SOLE
6526476
0
0
enGene Holdings Inc.
Common Shares
29286M105
4715000
500000
SH
SOLE
500000
0
0
KALA Bio, Inc.
Common Stock
483119202
3145556
443661
SH
SOLE
443661
0
0
Mineralys Therapeutics Inc.
Common Stock
603170101
23596817
2016822
SH
SOLE
2016822
0
0
Nkarta, Inc.
Common Stock
65487U108
19699998
3333333
SH
SOLE
3333333
0
0